Kolomansky, A.; Hiram-Bab, S.; Ben-Califa, N.; Liron, T.; Deshet-Unger, N.; Mittelman, M.; Oster, H.S.; Rauner, M.; Wielockx, B.; Neumann, D.;
et al. Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible. Int. J. Mol. Sci. 2020, 21, 3817.
https://doi.org/10.3390/ijms21113817
AMA Style
Kolomansky A, Hiram-Bab S, Ben-Califa N, Liron T, Deshet-Unger N, Mittelman M, Oster HS, Rauner M, Wielockx B, Neumann D,
et al. Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible. International Journal of Molecular Sciences. 2020; 21(11):3817.
https://doi.org/10.3390/ijms21113817
Chicago/Turabian Style
Kolomansky, Albert, Sahar Hiram-Bab, Nathalie Ben-Califa, Tamar Liron, Naamit Deshet-Unger, Moshe Mittelman, Howard S. Oster, Martina Rauner, Ben Wielockx, Drorit Neumann,
and et al. 2020. "Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible" International Journal of Molecular Sciences 21, no. 11: 3817.
https://doi.org/10.3390/ijms21113817
APA Style
Kolomansky, A., Hiram-Bab, S., Ben-Califa, N., Liron, T., Deshet-Unger, N., Mittelman, M., Oster, H. S., Rauner, M., Wielockx, B., Neumann, D., & Gabet, Y.
(2020). Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible. International Journal of Molecular Sciences, 21(11), 3817.
https://doi.org/10.3390/ijms21113817